Brooks Life Sciences supports and advances the research, pre-clinical and clinical scientific community with its highly-flexible and fully comprehensive sample management storage solutions, instruments, devices and consumables.

Our customers experience best-in-class solutions for automated storage systems for compounds and biospecimens, biorepository and biobanking services, pre-clinical and clinical sample storage consumables and instruments, cell therapy cryopreservation and cold chain solutions, to global sample preparation and analytical lab services.

CLICK A SAMPLE MANAGEMENT PATHWAY TO LEARN MORE:

Solutions to manage samples across the research continuum for:

  • Discovery, Compound Management and Biologics

    From sample acquisition and storage to high-throughput compound screening, we provide flexible, modular solutions that offer the security and reliability that assure accurate, on-time order fulfillment, reduced costs, and high throughput.

  • Biobanking Sample Management

    Brooks supports biobank organizations need for quality hardware and software that not only preserves their inventory of unique biological samples, but makes retrieving and testing samples easier for researchers.

  • Preclinical Research

    Brooks Life Sciences offers consulting services that identify the appropriate testing, sample processing, and data analysis methodologies for preclinical studies. We also provide support for the collection, processing, and analysis of those samples, plus storage for archival purposes.

  • Clinical Studies Sample Management

    Brooks Life Sciences partners with biotech and pharmaceutical customers to provide clinical trial sample management and processing that ensure the safety, integrity, and regulatory compliance essential for FDA review.

  • Cell Therapy

    From cell collection to therapeutic administration, Brooks Life Sciences has the cryopreservation storage solutions, transport handling devices, and storage containers that support the protection, monitoring, control, and auditing of cells throughout the cell therapy workflow.

  • Molecular Diagnostics - Biomarkers

    Brooks Life Sciences supports the development of molecular diagnostic research with comprehensive sample management, storage, and analytical services that remove variables, reduce risk, and yield richer study results.

  • Direct to Consumer Genomics / Genetics

    Brooks Life Sciences supports personal genetics companies with analysis, diagnostics, and consumer information. We manufacture sample collections kits, manage and process the samples, analyze the results, and manage the storage biobanks.

Solution Center

Consolidated intelligence on sample management at your finger tips.

Visit the Solution Center
Tube Wizard

Tube Selection Wizard

Publication Clinical Sample Management Compound Development Sample Management Pre-Clinical Sample Management
Patient Recruitment Dilemma

Solving the Patient Recruitment Dilemma

Publication Clinical Trial/Biological Sample Management Sample Prep & Genomic Services Basic Research Sample Management Clinical Sample Management Pre-Clinical Sample Management

Featured Blog

huricane

What is the Best Freezer Technology for Disaster Recovery Planning for Biomaterial?

Natural disasters, extended power outages, and equipment failures can affect our ability to maintain a consistent environment for storage of priceless biomaterial. Disaster recovery plans that include multiple backup systems are essential for all professional biostorage and research facilities. In disaster scenarios, the choice of freezer type can make the difference between complete sample loss and maintaining biomaterial integrity.

Read More

Upcoming Events

All Events
 
November 13, 2018 — November 14, 2018

SLAS Sample Management Symposium

8:00 AM Conferences

2018 SLAS Americas Sample Management Symposium: Managing Samples from Bench to Clinic

January 22, 2019 — January 25, 2019

Phacilitate: Leaders World

7:30 AM Conferences

Phacilitate Leaders World 2019 facilitates an event that will help improve, disrupt and drive the future of advanced therapies.